Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity.
artificial intelligence
biotechnology
healthy longevity
Journal
Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617
Informations de publication
Date de publication:
16 Oct 2024
16 Oct 2024
Historique:
received:
03
07
2024
accepted:
23
07
2024
medline:
18
10
2024
pubmed:
18
10
2024
entrez:
17
10
2024
Statut:
aheadofprint
Résumé
The recent unprecedented progress in ageing research and drug discovery brings together fundamental research and clinical applications to advance the goal of promoting healthy longevity in the human population. We, from the gathering at the Aging Research and Drug Discovery Meeting in 2023, summarised the latest developments in healthspan biotechnology, with a particular emphasis on artificial intelligence (AI), biomarkers and clocks, geroscience, and clinical trials and interventions for healthy longevity. Moreover, we provide an overview of academic research and the biotech industry focused on targeting ageing as the root of age-related diseases to combat multimorbidity and extend healthspan. We propose that the integration of generative AI, cutting-edge biological technology, and longevity medicine is essential for extending the productive and healthy human lifespan.
Identifiants
pubmed: 39418098
pii: 206135
doi: 10.18632/aging.206135
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM